{"id":"1084","presentation":"Tumor Ablation by Irreversible Electroporation (IRE) Augments CTLA-4 Checkpoint Inhibitor Immunotherapy","session":"SP115-4 - e-Posters II - Station 4","filename":"ACS_Clinical_Congress_2019_joseph_slaughter.pptx","speaker":"J. Slaughter","photo":"","cover":"https:\/\/s3.us-west-2.amazonaws.com\/us-cslide-prod-presentations\/acs2019\/1084\/jpg\/acs_clinical_congress_2019_joseph_slaughter\/thumbnails\/0.png","pdf":"\/file_access\/get_file\/E6488\/session_token\/a1482f45a70602295f28e0418b0626b4","what":"pdf","code":"","priority":["html5","pdf","jpg","thumbnail"]}
[speaker]
[presentation]
[session]